Safety Alerts Saves Lives
Safety Alerts  
Home Privacy About Us Contact Us Change Preferences

January 25, 2001

FDA Re-iterates Urgent Notice of Recalled Injectable Drugs

Washington, DC (SafetyAlerts) - The Food and Drug Administration (FDA) is urging individuals, health care organizations and medical product distributors to stop dispensing and/or distributing certain injectable medications marketed by Phyne Pharmaceuticals of Scottsdale, Ariz. AMRAM Inc. of Rathdrum, Idaho manufactured these products for Phyne Pharmaceuticals, who was their sole customer.

Patients who believe they might have been injured by these products should immediately consult with their health care provider. FDA is aware of three serious injuries associated with the use of one of the recalled products, Colchicine, labeled as containing .5mg/ml but actually formulated at a concentration of 5mg/ml.

On December 14, 2000, AMRAM Inc. notified Phyne Pharmaceuticals that AMRAM Inc. was recalling these products (previous notice) because they were manufactured under sub-standard conditions.

FDA is issuing today's warning because Phyne Pharmaceuticals has delayed taking prompt and appropriate action to remove these products from the market.

The nationwide recall follows FDA's recent inspections of Phyne Pharmaceuticals and AMRAM Inc. During the inspections, FDA found violations of requirements for good manufacturing standards for pharmaceuticals. These requirements help ensure that drug products are safe and effective. The violations FDA found demonstrate that the products lack assurance of sterility and potency.

Anyone in possession of these products is urged to contact and to return the products to Phyne Pharmaceuticals at 7950 East Red Field Rd., Scottsdale, Ariz. 85267, (800) 345-3391 or 480-998-4142, FAX (480) 443-4775. Phyne Pharmaceuticals has stated they will be providing specific return instructions to their customers by an "Urgent Voluntary Drug Recall" letter dated January 25, 2001.

The following is the most up-to-date list of products under recall by Phyne Pharmaceuticals. Some of the products are labeled with both AMRAM, Inc. and Phyne Pharamceuticals; however, some may bear one or the other company's name as the manufacturer and/or distributor with or without the other company's name listed.

All lot numbers and codes, strengths and sizes and expiration dates of the following injectable products are included in this recall:

Adenosine Monophosphate
Ascorbic Acid Injection
Beet Ascorbic Acid Injection
Vitamin B-12(Cyanocobolamin)
Disol, USP Brand of EDTA
Echinacea Homeopathic Injection
Edetate Disodium
Adrenal Cortex Extract (ACE) (See Addendum)
Folic Acid
Germanium Sesg.(Sesguloxide)
L-Glutathione or Glutathione
Human Chorionic Gonadotropin
Hydrochloric Acid
Iron 59 Injection
Liver Injection, Crude
Lypo-Vite Injection
Magnesium Chloride Injection
Procaine Hydrochloride Injection
Pyridoxine HCL (B-6)
Sodium Thiosalicylate
Superoxide Dismutase (S.O.D.)
L-Taurine Injection
Thiamine HCL
Thymus Extract
Choline Chloride
Chlorpheniramine Injection
Hydrogen Peroxide
MIC with Folic Acid
Pangamic Acid

See related HealthScout story HERE

Any adverse reactions experienced with the use of these products should also be reported to the FDA's MEDWATCH Program by phone at 1-800-FDA-1088, by fax at 1-800-FDA-0178, by mail at MEDWATCH, HF-2, FDA 5600 Fishers Lane, Rockville, MD 20852-9787.

Selected Recent Recalls

Health Professional:

Did you know?
During 2000 there were over
1050 products recalled in the United
States for safety reasons!

How many did you hear about?

Sign-up for SafetyAlerts by Email -
The free internet newsletter that could
some day literally save your life - or
the life of someone you know.

SafetyAlerts compiles comprehensive safety recall information for the United States. SafetyAlerts Newsletter is a free email service to warn consumers of faulty products and contaminated foods. For complete information regarding current recalls, past recalls and timely product warning notification visit:



The information contained herein has been obtained from sources that the Company believes to be reliable, however, the Company has not independently verified or confirmed the information and the recipient acknowledges that no representations or warranties are being made in connection with the use of the information.